TNNI3 and fibrosis: Injection of α‐myosin led to significant cardiac dysfunction (Figure 1a–c), concomitant with the increased serum cardiac troponin I (cTnI) levels (Figure 1d) and infiltration of immune cells as reflected by the inflammation area in the cardiac tissue (Figure 1e,f) and cardiac fibrosis (Figure 1g,h).